Risk management options for endocrine disruptors in national and
international programs
J. C. Lamb, IV, H. B. W. M. Ko�ter, R. Becker, A. Gies, L. Davies,
T. Inoue, A. Jacobs, G. Lyons, M. Matsumoto, and G. Timm
BBL Sciences, BBL, Inc., Reston, VA 20190, USA;
Organization for Economic Cooperation and Development, Paris, France;
American Chemical Council, USA;
UBA, Germany;
Department of Health and Ageing, Australia;
NIHS, Japan;
U.S. Food and Drug Administration, USA;
World Wildlife Fund, UK;
Chemical Management Policy Division, Ministry of Economy, Trade and
Industry, 1-3-1Kasumigaseki, Chiyoda-ku, Tokyo 100-8901, Japan;
U.S. Environmental Protection Agency, USA
Abstract: This workshop was convened to address common issues
and concerns associated with risk management of endocrine-disrupting
chemicals (EDCs). The talks described the tools and policies for key
Japanese, Australian, German, and U.S. regulatory agencies. The agencies
participating in the workshop were responsible for the regulation of
various substances including: chemicals, pesticides, environmental contamination,
pharmaceuticals, and food additives. The panel also described the role
of the Organization for Economic Cooperation and Development (OECD)
in standardizing the tools and validation of testing and screening methods.
The panel also included nongovernmental organizations presenting the
views of the World Wildlife Fund, and the chemical industry from industrialized
nations; each organization described its concerns and proposed approaches
to risk management of EDCs. This summary highlights the most important
areas of common points of view of government, industry, and environmentalists.
We also try to identify issues upon which viewpoints diverge.
*Report from a SCOPE/IUPAC project: Implication of
Endocrine Active Substances for Human and Wildlife (J. Miyamoto and
J.Burger, editors). Other reports are published in this issue,
pp. 1617-2615.